Cargando…

Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report

Drug-induced pancreatitis occurs rarely but should be considered when more common causes have been ruled out. While simple to treat, mortality increases should it progress to a necrotizing process. Here, we present the case of a patient simultaneously using two drugs associated with pancreatitis, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Rio, Teresa, Ubhi, Manveer, Irizarry Nieves, Luis E, Fermin, Basilides, Sury, Kala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193513/
https://www.ncbi.nlm.nih.gov/pubmed/37214053
http://dx.doi.org/10.7759/cureus.37754
_version_ 1785043842296184832
author Del Rio, Teresa
Ubhi, Manveer
Irizarry Nieves, Luis E
Fermin, Basilides
Sury, Kala
author_facet Del Rio, Teresa
Ubhi, Manveer
Irizarry Nieves, Luis E
Fermin, Basilides
Sury, Kala
author_sort Del Rio, Teresa
collection PubMed
description Drug-induced pancreatitis occurs rarely but should be considered when more common causes have been ruled out. While simple to treat, mortality increases should it progress to a necrotizing process. Here, we present the case of a patient simultaneously using two drugs associated with pancreatitis, which we considered acted synergistically and consequently worsened the patient's outcome.
format Online
Article
Text
id pubmed-10193513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101935132023-05-19 Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report Del Rio, Teresa Ubhi, Manveer Irizarry Nieves, Luis E Fermin, Basilides Sury, Kala Cureus Internal Medicine Drug-induced pancreatitis occurs rarely but should be considered when more common causes have been ruled out. While simple to treat, mortality increases should it progress to a necrotizing process. Here, we present the case of a patient simultaneously using two drugs associated with pancreatitis, which we considered acted synergistically and consequently worsened the patient's outcome. Cureus 2023-04-18 /pmc/articles/PMC10193513/ /pubmed/37214053 http://dx.doi.org/10.7759/cureus.37754 Text en Copyright © 2023, Del Rio et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Del Rio, Teresa
Ubhi, Manveer
Irizarry Nieves, Luis E
Fermin, Basilides
Sury, Kala
Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title_full Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title_fullStr Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title_full_unstemmed Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title_short Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
title_sort necrotizing pancreatitis secondary to hydrochlorothiazide and alogliptin: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193513/
https://www.ncbi.nlm.nih.gov/pubmed/37214053
http://dx.doi.org/10.7759/cureus.37754
work_keys_str_mv AT delrioteresa necrotizingpancreatitissecondarytohydrochlorothiazideandalogliptinacasereport
AT ubhimanveer necrotizingpancreatitissecondarytohydrochlorothiazideandalogliptinacasereport
AT irizarrynievesluise necrotizingpancreatitissecondarytohydrochlorothiazideandalogliptinacasereport
AT ferminbasilides necrotizingpancreatitissecondarytohydrochlorothiazideandalogliptinacasereport
AT surykala necrotizingpancreatitissecondarytohydrochlorothiazideandalogliptinacasereport